Fitch also affirmed ratings ranging from “BB-” to “CCC-” on certain notes. The outlook is negative.
As well as “leverage well above that of its closest peers,” CHS is expected to continue to feel the effects of the pandemic in its operating results even as the 78-hospital system is lessening its reliance on contract labor, Fitch said.
CHS has a weaker operating profile than its peers, such as Dallas-based Tenet Health and Nashville, Tenn.-based HCA Healthcare, and primarily operates in smaller population areas than such peers, Fitch also noted.
CHS announces its second quarter financial results Aug. 2.